Refine Results
  1. "Myeloma"
Formats
  1. Meeting Abstract (143)
  2. Journal Article (139)
  3. Book Section (6)
  4. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (289)
  2. Hematologic Oncology, Division of (289)
  3. Myeloma (289)
  4. Myeloma Service (289)
  5. Myeloma Disease Management Team (197)
  6. Hematologic Oncology Disease Management Team (195)

More Groups

People
  1. Hani Hassoun (138)
  2. Carl Landgren (92)
  3. Heather Landau (92)
  4. Alexander Lesokhin (90)
  5. Nikoletta Lendvai (76)
  6. Sergio Giralt (72)

More People

Years
  1. 2019 (1)
  2. 2018 (40)
  3. 2017 (39)
  4. 2016 (40)
  5. 2015 (31)
  6. 2014 (39)

More Years

Publications
  1. Blood (94)
  2. Journal of Clinical Oncology (22)
  3. Biology of Blood and Marrow Transplantation (14)
  4. Leukemia and Lymphoma (14)
  5. Haematologica (12)
  6. Bone Marrow Transplantation (10)

More Publications

Publishers
  1. American Society of Hematology (97)
  2. Nature Publishing Group (31)
  3. Elsevier Inc. (28)
  4. American Society of Clinical Oncology (22)
  5. Taylor & Francis Group (15)
  6. American Medical Association (12)

More Publishers

Results (289)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Significant nationwide variability in the costs and hospital mortality rates of autologous stem cell transplantation for multiple myeloma: An analysis of the Nationwide Inpatient Sample database
    Journal Article

    Liu, Y.; Han, H.; Shah, G.; Giralt, S.; Landgren, C. O.; He, J.; Lesokhin, A. M.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Phase 1, multicenter, open-label study of single-agent bispecific antibody T-cell engager GBR 1342 in relapsed/refractory multiple myeloma
    Meeting Abstract

    Richter, J. R.; Wermke, M.; Kauh, J. S.; Back, J.; Salhi, Y.; Reddy, V.; Bayever, E.; Landgren, C. O.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): A dose escalation and expansion phase 1 trial
    Journal Article

    Trudel, S.; Lendvai, N.; Popat, R.; Voorhees, P. M.; Reeves, B.; Libby, E. N.; Richardson, P. G.; Anderson, L. D. Jr; Sutherland, H. J.; Yong, K.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma
    Journal Article

    Tageja, N.; Korde, N.; Kazandjian, D.; Panch, S.; Manasanch, E.; Bhutani, M.; Kwok, M.; Mailankody, S.; Yuan, C.; Stetler-Stevenson, M.; more...
    Bone Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma
    Journal Article

    Ledergor, G.; Weiner, A.; Zada, M.; Wang, S. Y.; Cohen, Y. C.; Gatt, M. E.; Snir, N.; Magen, H.; Koren-Michowitz, M.; Herzog-Tzarfati, K.; more...
    Nature Medicine (2018)

    Fulltext@MSK | Save
  • Remission and progression-free survival in patients with newly diagnosed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone: Five-year follow-up of a phase 2 clinical trial
    Journal Article

    Kazandjian, D.; Korde, N.; Mailankody, S.; Hill, E.; Figg, W. D.; Roschewski, M.; Landgren, O.
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Detection of clonal rearrangements in multiple myeloma samples using LymphoTrack Assays
    Meeting Abstract

    Huang, Y.; Jacobsen, A.; Panganiban, J.; Vigil, E.; Hutt, K.; Heilman, J.; Blankfard, M.; Stenzel, T.; Rustad, E. H.; Hultcrantz, M.; more...
    Journal of Molecular Diagnostics (2018)

    Fulltext@MSK | Save
  • Addendum: Low-value approvals and high prices might incentivize ineffective drug development
    Journal Article

    Prasad, V.; McCabe, C.; Mailankody, S.
    Nature Reviews Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Dietary intake is associated with risk of multiple myeloma and its precursor disease
    Journal Article

    Thordardottir, M.; Lindqvist, E. K.; Lund, S. H.; Costello, R.; Burton, D.; Steingrimsdottir, L.; Korde, N.; Mailankody, S.; Eiriksdottir, G.; Launer, L. J.; more...
    PLoS ONE (2018)

    Fulltext@MSK | Save
  • Second malignancies in patients with myeloproliferative neoplasms: A population-based cohort study of 9379 patients
    Journal Article

    Landtblom, A. R.; Bower, H.; Andersson, T. M. L.; Dickman, P. W.; Samuelsson, J.; Björkholm, M.; Kristinsson, S. Y.; Hultcrantz, M.
    Leukemia (2018)

    Fulltext@MSK | Save